Page last updated: 2024-10-31

nabumetone and Renal Insufficiency

nabumetone has been researched along with Renal Insufficiency in 1 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pal, B1
Hutchinson, A1
Bhattacharya, A1
Ralston, A1

Other Studies

1 other study available for nabumetone and Renal Insufficiency

ArticleYear
Cardiac arrest due to severe hyperkalaemia in patient taking nabumetone and low salt diet.
    BMJ (Clinical research ed.), 1995, Dec-02, Volume: 311, Issue:7018

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Diet, Sodium-Restricted; Heart Arrest; Hum

1995